BCIQ Profiles

Company Profile Report
0608 qts
BioCentury & Getty Images

Product Development

June 8 Quick Takes: FDA approves Prevnar 20; plus Bayer’s BlueRock, Innovent-IASO, Strateos, Aclaris, Incyte and more

Jun 9, 2021 | 12:06 AM GMT

CDC’s Advisory Committee on Immunization Practices (ACIP) will meet in October to discuss and update recommendations on adult immunizations with pneumococcal vaccines including Prevnar 20 from Pfizer Inc. (NYSE:PFE) after its approval late Tuesday. According to the company, it’s the first approval of a conjugate vaccine that helps protect against

Read the full 772 word article

How to gain access

Continue reading with a
two-week free trial.